close
MENU
General Business
5 mins to read

Volpara Health eyes acquisitions to further US expansion

ASX-listed company looks at several US companies in various degrees of Covid-distress.

Julie Iles Mon, 25 May 2020

ASX-listed and Wellington-based medical device software company Volpara Health Technologies is looking to further expand its US market.

The imaging software uses artificial intelligence to aid in the early detection of breast cancer, and is considered the world-leading analyser of fibroglandular

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Contact the Writer: julie@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Volpara Health eyes acquisitions to further US expansion
General Business,
83722
true